Aspergillus antigen (galactomannan) - fungal diagnostics webinar (with Q&A) invasive aspergillosis

Contents:
- How the test works
- Video protocols for carrying out the different assays currently available from major, including any point-of-care (‘bedside’) tests
- How to interpret and report results, including any important caveats and potential sources of false results
- Performance (sn/sp/PPV/NPV) in different diseases and patient groups
- Illustrated with recent scientific research and medical images
For:
- Medical laboratory staff wishing to improve or expand their testing capabilities for fungal infections, particularly point-of-care tests
- Specialist clinicians wishing to better understand how to select the appropriate test(s) for their clinical situation and interpret the results
Q&A session discusses questions asked by the live webinar attendees, including:
- How can you diagnose COVID-associated aspergillosis, and how do you take respiratory samples safely in these patients? Is antibody testing useful here?
- Can these tests be used for detecting Sporothrix, or Fusarium keratitis, or non-fumigatus non-flavus Aspergillus species?
- Can you use this test on sputum?

[@harshpatel2765]

What does the Aspergillus (Galactomannan) Antigen index 4.94 mean? Does it mean Invasive Aspergillus or further tests are required to identify Invasive Aspergillus?

[@LearnwithDrAksh]

Look for Clinical & host factors - if present to be treated